The effect of ixekizumab on axial manifestations in patients with psoriatic arthritis from two phase III clinical trials: SPIRIT-P1 and SPIRIT-P2.
Therapeutic advances in musculoskeletal disease（2023）
摘要
IXE is effective in improving axial symptoms in patients with active PsA presenting with axial manifestations.
更多查看译文
关键词
psoriatic arthritis,ixekizumab,axial manifestations
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要